Low Serum Methylglyoxal Levels Correlate with Psoriasis Severity and Inflammatory Response Indices
Psoriasis is a multifactorial inflammatory disease. Methylglyoxal (MG) is a highly reactive dicarbonyl compound responsible for dicarbonyl stress in some inflammatory conditions, and it may play a role in the etiopathogenesis of psoriasis. <b>Methods:</b> A total of 50 patients with psor...
Saved in:
| Main Authors: | Aleksandra Damasiewicz-Bodzek, Agnieszka Nowak, Maciej Maciejczyk, Sławomir Waligóra, Brygida Przywara-Chowaniec |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Pathophysiology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1873-149X/32/1/8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methotrexate plus narrow band ultraviolet B (NBUVB) versus methotrexate alone in the treatment of moderate to severe plaque psoriasis: A randomized clinical trial
by: Dhan Keshar Khadka, et al.
Published: (2016-01-01) -
Methotrexate plus narrow band ultraviolet B (NBUVB) versus methotrexate alone in the treatment of moderate to severe plaque psoriasis: A randomized clinical trial
by: Dhan Keshar Khadka, et al.
Published: (2016-01-01) -
Sex Differences in Dermatology Life Quality Index (DLQI) among Patients with Psoriasis
by: Mikkel Bak Jensen, et al.
Published: (2024-12-01) -
Methotrexate Versus Methotrexate Plus Folic Acid in the Treatment of Moderate to Severe Plaque Psoriasis: A Randomized Clinical-Trial
by: D.K. Khadka, et al.
Published: (2016-09-01) -
Methotrexate Versus Methotrexate Plus Folic Acid in the Treatment of Moderate to Severe Plaque Psoriasis: A Randomized Clinical-Trial
by: D.K. Khadka, et al.
Published: (2016-09-01)